Beam Therapeutics Inc (BEAM) PT Raised to $47 at Leerink Partners

March 25, 2026 1:09 PM

Leerink Partners analyst Mani Foroohar raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $47.00 (from $42.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found